This episode begins the virus-family–specific chapters with two groups of small, non-enveloped DNA viruses: papillomaviruses and polyomaviruses. Drawing from Murray’s Chapter 41, it explores their structural simplicity and profound clinical consequences.

The narrative centres first on Human Papillomavirus (HPV). These viruses infect stratified squamous epithelium, producing benign warts or, in high-risk strains, driving oncogenic transformation. The viral proteins E6 and E7 interfere with tumour suppressor pathways, linking infection to cervical, anogenital, and oropharyngeal cancers. Vaccination emerges as a transformative public health intervention.

The episode then shifts to polyomaviruses, including JC virus and BK virus. These viruses typically remain latent but reactivate in immunocompromised hosts. JC virus can cause progressive multifocal leukoencephalopathy (PML), while BK virus may complicate renal transplantation.

Conceptually, these viruses illustrate how small genomes can exert large biological influence. Clinically, they reinforce the interplay between immunity, persistence, and oncogenesis.

Key Takeaways

* Papillomaviruses and polyomaviruses are small, non-enveloped DNA viruses

* HPV infects epithelial tissue and may cause malignancy

* Viral oncogenes disrupt host tumour suppressor pathways

* Polyomaviruses establish latency and reactivate with immunosuppression

* Vaccination significantly reduces HPV-associated disease

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe